Moyses Neto Miguel, Silva Gyl Eanes Barros, Costa Roberto S, Romão Elen A, Vieira Neto Osvaldo Merege, Dantas Marcio
Division of Nephrology, Department of Internal Medicine, School of Medicine of Ribeirão Preto, Universidade de São Paulo, Brazil.
Arq Bras Endocrinol Metabol. 2012 Jul;56(5):331-5. doi: 10.1590/s0004-27302012000500009.
A 19-year-old female with type 1 diabetes for four years, and a 73-year-old female with type 2 diabetes for twenty years developed sudden-onset nephrotic syndrome. Examination by light microscopy, immunofluorescence, and electron microscopy (in one case) identified minimal change disease (MCD) in both cases. There was a potential causative drug (meloxicam) for the 73-year-old patient. Both patients were treated with prednisone and responded with complete remission. The patient with type 1 diabetes showed complete remission without relapse, and the patient with type 2 diabetes had two relapses; complete remission was sustained after associated treatment with cyclophosphamide and prednisone. Both patients had two years of follow-up evaluation after remission. We discuss the outcomes of both patients and emphasize the role of kidney biopsy in diabetic patients with an atypical proteinuric clinical course, because patients with MCD clearly respond to corticotherapy alone or in conjunction with other immunosuppressive agents.
一名患有1型糖尿病四年的19岁女性和一名患有2型糖尿病二十年的73岁女性突然出现肾病综合征。通过光学显微镜、免疫荧光和电子显微镜检查(其中一例),在两例中均确诊为微小病变性肾病(MCD)。73岁患者存在一种潜在的致病药物(美洛昔康)。两名患者均接受泼尼松治疗并完全缓解。1型糖尿病患者完全缓解且未复发,2型糖尿病患者复发两次;联合环磷酰胺和泼尼松治疗后持续完全缓解。两名患者在缓解后均进行了两年的随访评估。我们讨论了两名患者的治疗结果,并强调肾活检在具有非典型蛋白尿临床病程的糖尿病患者中的作用,因为MCD患者对单独使用皮质激素治疗或与其他免疫抑制剂联合治疗有明显反应。